跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72 条关于
“ARPIs”
全部
72
临床试验
37
药物
3
机构
0
资讯
32
去年
ARPIs Show Similar Efficacy in mHSPC Regardless of Disease Volume; Drug Selection Should Focus on Patient-Specific Factors
9个月前
Long-Term ARPI Data Reinforces Survival Benefits in Metastatic Prostate Cancer While Real-World Evidence Gaps Persist
去年
Prior Local Therapy Does Not Compromise ARPI Treatment in mCRPC
去年
Artera's AI Algorithm Identifies Which Prostate Cancer Patients Benefit from Intensive Therapy, Earning Best of ASCO Recognition
2年前
Eli Lilly's Lutetium Zadavotide Guraxetan Shows Promise in Metastatic Castration-Resistant Prostate Cancer
去年
Novel Therapeutic Classes Transform Future Treatment Paradigm for Metastatic Castration-Resistant Prostate Cancer
29天前
Metabolic Syndrome Emerges Rapidly in First Year of ADT-ARPI Therapy for Prostate Cancer
去年
Triplet Therapy vs. Doublet Therapy in Metastatic Prostate Cancer: A Treatment Debate
去年
Lutetium Lu 177 Vipivotide Tetraxetan Shows Promise in Prostate Cancer Treatment
3个月前
J&J's Erleada Shows Dramatic Efficacy in High-Risk Prostate Cancer Surgery Trial
第 1 页,共 4 页
上一页
下一页